Ｍ－ＧＮＩ：(Progress of Disclosed Matters) First Patient Enrollment of F351 Phase III Clinical Trial in China - 有報キャッチャー

Ｍ－ＧＮＩ（2160）　(Progress of Disclosed Matters) First Patient Enrollment of F351 Phase III Clinical Trial in China 2022/01/17

/-

読み込み中…